Christopher R. Gordon

Insider Reports History

Entity
Individual
Location
C/O Bain Capital, Llc, John Hancock Tower, 200 Clarendon Street, Boston, MA
Signature
/s/ Christopher R. Gordon
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher R. Gordon:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Cerevel Therapeutics Holdings, Inc. Director, 10%+ Owner Common Stock 0 $0 $41.18 Aug 1, 2024 Direct
Cerevel Therapeutics Holdings, Inc. Director, 10%+ Owner Common Stock 0 $0 $41.18 Aug 1, 2024 Indirect
Cerevel Therapeutics Holdings, Inc. Director, 10%+ Owner Stock Option (Right to Buy) 0 Aug 1, 2024 Direct

Insider Reports Filed by Christopher R. Gordon

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CERE Cerevel Therapeutics Holdings, Inc. Aug 1, 2024 4 $0 4 Aug 5, 2024 Director, 10%+ Owner
CERE Cerevel Therapeutics Holdings, Inc. Jun 5, 2024 1 $0 4 Jun 7, 2024 Director, 10%+ Owner
CERE Cerevel Therapeutics Holdings, Inc. Oct 16, 2023 1 $125M 4 Oct 18, 2023 Director, 10%+ Owner
CERE Cerevel Therapeutics Holdings, Inc. Jun 7, 2023 3 $0 4 Jun 9, 2023 Director, 10%+ Owner
CERE Cerevel Therapeutics Holdings, Inc. Jun 14, 2022 1 $0 4 Jun 16, 2022 Director, 10%+ Owner
CERE Cerevel Therapeutics Holdings, Inc. Jun 10, 2021 1 $0 4 Jun 14, 2021 Director, 10%+ Owner